Purchases and Sales Made in Q4 2022 in Clovis Oncology, Inc. (CLVS)
This table provides information about the institutional ownership of Clovis Oncology, Inc. (CLVS) during Q4 2022. The information is specifically focused on institutions that hold shares of Clovis Oncology, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 13, 2023
Q4 2022
|
S&T Bank
Indiana, PA |
BUY
|
- |
20K+ 50.0% |
$1K - $26K
|
60K
$5.4K
|
|
Feb 17, 2023
Q4 2022
|
Coppell Advisory Solutions Corp.
Coppell, TX |
BUY
|
- |
265New |
$13.3 - $345
|
265
$23.8
|
|
May 19, 2023
Q4 2022
|
Coppell Advisory Solutions LLC
Coppell, TX |
BUY
|
- |
265New |
$13.3 - $345
|
265
$23.8
|
|
Feb 07, 2023
Q4 2022
|
Ifp Advisors, Inc
|
BUY
|
- |
50+ 0.5% |
$2.5 - $65
|
10.1K
$905
|
|
Feb 13, 2023
Q4 2022
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-1.66K- 3.52% |
$82.8 - $2.15K
|
45.3K
$4.08K
|
|
Mar 06, 2023
Q4 2022
|
Rockefeller Capital Management L.P.
New York, NY |
SELL
|
- |
-6K- 94.12% |
$300 - $7.8K
|
375
$33.8
|
|
Feb 14, 2023
Q4 2022
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-8.1K- 40.33% |
$405 - $10.5K
|
12K
$1.08K
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-10K- 93.83% |
$501 - $13K
|
660
$59.4
|